Clinical trials
Pulmonary clinical trials
Below are recruiting pulmonary clinical trials, each written for real people, not researchers. We’re tracking 1,310 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06383975Recruiting
Two new treatments for AF that returned after first procedure
This trial tests two new treatments for persistent atrial fibrillation that came back after an initial procedure. One uses a targeted chemical injection, the other uses a special energy field to re-isolate the veins involved.
BrugesAges 18 years+ - NCT02480283Recruiting
Study of cannabis smoke and lung immune response
This study compares people who smoke cannabis daily with people who have never used cannabis. It looks at how cannabis smoke affects lung stress and the lungs’ immune defenses, using health tests and urine screening to keep participants safe.
Aurora, ColoradoAges 18–55 - NCT07719231Recruiting
Understanding body signals during COPD flare-ups
This study explores how people with COPD perceive body signals during a sudden worsening of symptoms (exacerbation) that requires a hospital stay. It aims to improve symptom management and patient care.
IstanbulAges 40–75 - NCT07719959Recruiting
3D airway imaging to guide breathing tube placement during lung surgery
This trial tests whether using a 3D model of your airway helps doctors place a breathing tube more precisely during video-assisted lung surgery. It may improve safety and accuracy.
Beijing, Beijing MunicipalityAges 18–75 - NCT05053061Recruiting
Telerehabilitation program for people with COPD at home
This trial tests whether supervised rehab exercises delivered by phone/video (telerehabilitation) can help people living with COPD. You may be a fit if you’re an adult with COPD who hasn’t done pulmonary rehabilitation before and can use a smartphone.
IzmirAges 18 years+ - NCT07714252Enrolling by invitation
Virtual palliative care team for veterans with heart or lung disease
This study tests a virtual team of nurses and social workers who provide palliative care to veterans with heart failure, COPD, or interstitial lung disease. The goal is to improve quality of life by offering extra support at home.
Phoenix, ArizonaAges 18 years+ - NCT07709754Recruiting
Lung stimulation for hard-to-control asthma
This trial tests a device that stimulates the lung to help people whose asthma is not controlled by standard treatments. It may offer a new option for those who still have symptoms despite using inhalers or biologic medicines.
Denver, ColoradoAges 18–75 - NCT07707271Recruiting
Continuous vs. interval exercise for COPD
This trial compares two types of exercise training—steady moderate exercise versus short bursts of higher intensity—to see which is more helpful for people with COPD. It aims to find a better way to improve your breathing and fitness.
Thessaloniki, ExohiAges Any age - NCT06643325Recruiting
Gastric emptying after traumatic injuries
This study looks at how quickly the stomach empties after a traumatic injury. It may help doctors understand digestion in injured patients.
WinterthurAges 18 years+ - NCT07704567Recruiting
Using MoblO2 to maintain oxygen levels during activity
This study tests a device called MoblO2 to help people with COPD or interstitial lung disease keep their oxygen levels up during activity. If you normally use oxygen when you walk or exert yourself, this might help you stay active more safely.
Denver, ColoradoAges 25–95 - NCT06200311Recruiting
Atrial fibrillation ablation to prevent heart damage in women and men
This trial tests whether a procedure called AF ablation (which treats irregular heartbeats) can stop further damage to the heart muscle caused by atrial fibrillation. It may help people with both atrial fibrillation and early signs of heart muscle weakening.
GroningenAges 65–80 - NCT05925764Recruiting
AI tool to help grade lung adenocarcinoma biopsies
This trial tests an artificial intelligence (AI) method that reads whole slide pathology images to classify how aggressive your lung adenocarcinoma is. It may help doctors diagnose the lung cancer grading system more accurately using existing lab slides after surgery.
Zunyi, GuizhouAges 18–85 - NCT06479603RecruitingPhase 4
Nintedanib for lung scarring from sarcoidosis
This trial tests whether nintedanib, a drug that slows lung scarring, can help people with sarcoidosis-related lung fibrosis. It is for those who still have breathlessness or cough despite stable treatment.
ChandigarhAges Any age - NCT07684820RecruitingPhase 2
A study of ExPD-101 for COPD with chronic bronchitis and frequent flare-ups
This study tests an experimental drug (ExPD-101) given daily as a pill for 52 weeks for people with COPD who have chronic bronchitis and frequent flare-ups. It compares the drug to a placebo (inactive pill) to see if it reduces flare-ups and improves symptoms.
Phoenix, ArizonaAges 40–85 - NCT06243146Recruiting
Oxygen adjustment to prevent lung problems after surgery
This study is testing whether adjusting the amount of oxygen given during and after surgery can help reduce lung complications in people having lung surgery with a special breathing tube. The goal is to find a safer oxygen level that might keep your lungs healthier.
Chengdu, SichuanAges 18–80 - NCT07672548Recruiting
Pilates for better breathing and quality of life in postmenopausal women
This 10-week study tests whether Pilates exercises can improve lung function and overall well-being in postmenopausal women who have breathing problems. It may help you feel stronger and breathe easier.
AmmanAges 50–60 - NCT07668518RecruitingPhase 1/Phase 2
Study of KIT2014 for moderate to severe COPD
This trial tests a new medicine called KIT2014 in people with moderate to severe COPD. It aims to see if the drug is safe, tolerable, and helps improve breathing and COPD symptoms.
Charlestown, New South WalesAges 40–80 - NCT07656259Recruiting
Comparing breathing support methods in the heart ICU
This study compares different ways to support breathing in patients who need a ventilator in the cardiac intensive care unit. It aims to find the best approach for people with certain heart conditions, like cardiogenic shock or heart failure.
Rochester, MinnesotaAges 18 years+ - NCT07662603Recruiting
Breathing exercise program for teens with Behcet's after lung surgery
This trial is for teenagers with Behcet's disease who have had a specific lung surgery to remove a clot. It tests a breathing exercise program to help improve lung function after surgery.
Giza, DokkiAges 13–17 - NCT07646587RecruitingPhase 2
Safety Study of WIN378 for Moderate-Severe COPD
This study tests a new drug called WIN378 in people with moderate-to-severe COPD (chronic lung disease). It will check if the drug is safe and how the body processes it, which may help improve breathing and reduce flare-ups.
Los Angeles, CaliforniaAges 40–80 - NCT07652658RecruitingPhase 2
Study of AZD8965 for people with IPF
This trial tests a new drug called AZD8965 for Idiopathic Pulmonary Fibrosis (IPF). It aims to see if the drug can help people with IPF either on current treatments or not on standard therapy.
Birmingham, AlabamaAges 40 years+ - NCT07648082Recruiting
Understanding Breathlessness in Lung Disease
This study explores how people experience and perceive breathlessness, whether they have a known lung condition or are healthy. Researchers want to understand breathlessness better to potentially improve how it's managed and treated.
Leicester, LeicestershireAges 18–100 - NCT07640451RecruitingPhase 2
HRS-9821 inhalation treatment for moderate to severe COPD
This trial tests whether an inhaled medication called HRS-9821 can help people with moderate to severe COPD (chronic obstructive pulmonary disease) breathe better and reduce symptoms. You inhale the medication, and researchers will measure how well your lungs work and how you feel over time.
Shanghai, Shanghai MunicipalityAges 40–80 - NCT07638176Recruiting
Better breathing support during lung surgery
This study tests whether adjusting breathing machine settings during lung surgery improves oxygen levels and recovery. If you're having lung surgery, this trial may help doctors keep you safer during the procedure.
SeoulAges 19–100
Hear when a new Pulmonary trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for pulmonary?
- Yes. Clin2 currently lists 1,310 recruiting pulmonary studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a pulmonary trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a pulmonary trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.